If you have been given login details for the healthcare provider section of this website, please enter them below. You will receive login details once one of your patients is registered.

We use cookies for the essential functioning of the site and for analytics purposes only. By entering the site, we assume you are happy to receive these cookies. Click here for more information on cookies.

The OCREVUS Pregnancy Exposure Registry is a global observational registry of pregnant women with multiple sclerosis (MS) who have been exposed to OCREVUS® (ocrelizumab) during the 6 months prior to their last menstrual period (LMP) or at any time during pregnancy. An internal comparator group will consist of pregnant women with MS who were not exposed to any MS disease-modifying therapies (DMTs) during the 6 months prior to their LMP or at any time during pregnancy (apart from glatiramer acetate). Women must be 18 years or older to be able to participate.

If you have any problems accessing the healthcare provider portal, please contact the registry team at 1 (833) 872-4370.

This site uses cookies including for the essential functioning of the site and for analytical purposes. For more information about these cookies and the choices you have to manage them, please view our Privacy Policy or visit the Interactive Advertising Bureau

By clicking through the website, we understand this means you have accepted our cookies.